TYRA

TYRA

USD

Tyra Biosciences Inc. Common Stock

$15.000-0.210 (-1.381%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$15.210

高値

$15.720

安値

$14.540

出来高

0.09M

企業ファンダメンタルズ

時価総額

799.5M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.22M

取引所

NMS

通貨

USD

52週レンジ

安値 $6.42現在値 $15.000高値 $17.78

関連ニュース

Analyst Upgrades

Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35

Raymond James analyst Chris Raymond initiates coverage on Tyra Biosciences with a Strong Buy rating and announces Price Target of $35.

もっと見る
Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences with a Buy and maintains $30 price target.

もっと見る
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target
PR Newswire

Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

もっと見る
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
PR Newswire

Tyra Biosciences Announces Participation at Upcoming Investor Events

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

もっと見る
Tyra Biosciences Announces Participation at Upcoming Investor Events